Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hahn

Showing results (671-680 of 764) with videos related to

Pageof 77
Sort By:
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.
Nature Biotechnology|October 7, 2024
Scalable, compressed phenotypic screening using pooled perturbationsNuo Liu, Walaa E Kattan, Benjamin E Mead, et al.
Cancer Discovery|December 28, 2022
A Ubiquitination Cascade Regulating the Integrated Stress Response and Survival in CarcinomasLisa D Cervia, Tsukasa Shibue, Ashir A Borah, et al.
Cell|March 5, 2021
An expanded universe of cancer targetsWilliam C Hahn, Joel S Bader, Theodore P Braun, et al.
Cell Metabolism|February 26, 2019
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione DepletionIsaac S Harris, Jennifer E Endress, Jonathan L Coloff, et al.
Nature Genetics|June 30, 2018
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancerSrinivas R Viswanathan, Marina F Nogueira, Colin G Buss, et al.
Cell Reports|February 23, 2022
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancerStephen Tang, Vidyalakshmi Sethunath, Nebiyou Y Metaferia, et al.
Cell|September 6, 2011
BET bromodomain inhibition as a therapeutic strategy to target c-MycJake E Delmore, Ghayas C Issa, Madeleine E Lemieux, et al.
Pageof 77

Showing results (671-680 of 764) with videos related to

Sort By:
Pageof 77
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of <i>TP53</i> missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.
Nature Biotechnology|October 7, 2024
Scalable, compressed phenotypic screening using pooled perturbationsNuo Liu, Walaa E Kattan, Benjamin E Mead, et al.
Cancer Discovery|December 28, 2022
A Ubiquitination Cascade Regulating the Integrated Stress Response and Survival in CarcinomasLisa D Cervia, Tsukasa Shibue, Ashir A Borah, et al.
Cell|March 5, 2021
An expanded universe of cancer targetsWilliam C Hahn, Joel S Bader, Theodore P Braun, et al.
Cell Metabolism|February 26, 2019
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione DepletionIsaac S Harris, Jennifer E Endress, Jonathan L Coloff, et al.
Nature Genetics|June 30, 2018
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancerSrinivas R Viswanathan, Marina F Nogueira, Colin G Buss, et al.
Cell Reports|February 23, 2022
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancerStephen Tang, Vidyalakshmi Sethunath, Nebiyou Y Metaferia, et al.
Cell|September 6, 2011
BET bromodomain inhibition as a therapeutic strategy to target c-MycJake E Delmore, Ghayas C Issa, Madeleine E Lemieux, et al.
Pageof 77